Smruthi Organics has informed that the ‘Trading Window’ pursuant to the Company’s Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons pursuant to Regulation 9(1) and schedule B of the SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended by SEBI (Prohibition of Insider Trading) Regulations, 2018, will remain closed with effect from Wednesday 01st July, 2026 till 48 hours after the declaration of Un-Audited Financial Results of the Company for the first quarter ended June 30 ,2026. The date of Meeting of the Board of Directors of the Company, to approve the Un-Audited Financial Results of the Company for the first quarter ended June 30, 2026 will be informed in due course. All Insiders of the Company are requested to take note of this intimation and not to deal with / purchase or sale of the Company's securities during the Window Closure period.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1904.65 |
| Dr. Reddys Labs. | 1374.55 |
| Cipla | 1458.45 |
| Zydus Lifesciences | 1141.00 |
| Lupin | 2476.10 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: